🇺🇸 FDA
Patent

US 11253546

Bispecific OR-gate chimeric antigen receptor responsive to CD19 and CD20

granted A61KA61K2039/505A61K2239/29

Quick answer

US patent 11253546 (Bispecific OR-gate chimeric antigen receptor responsive to CD19 and CD20) held by The Regents of the University of California expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/505, A61K2239/29, A61K2239/48, A61K35/17